Mai Capital Management 13F: Adds $31K to Astera Labs (ALAB) Stake

Mai Capital Management Boosts Holdings in Astera Labs

Mai Capital Management increased its position in Astera Labs, Inc. (NASDAQ: ALAB) by 2.91% during the latest reporting period, according to its Form 13F filing with the SEC. The firm added 63 shares of the semiconductor connectivity specialist, bringing its total to 2,226 shares. At the close of the period, the position was valued at $1,100,534.

This 13F filing reflects the fund's holdings as of May 15, 2026. Because these regulatory filings are backward-looking documents, they show a snapshot of a portfolio at a specific moment and might not represent the fund's current holdings or market views today.

Growth in the Semiconductor Connectivity Space

The modest addition by Mai Capital Management builds on its existing position, raising its holdings from 2,163 shares to the current 2,226 shares. Over the past few quarters, institutional sentiment around Astera Labs has been mixed. While some larger firms like Tudor Investment and Voya Investment Management trimmed their positions in early May 2026, others have been buyers. For instance, Swiss National Bank and PNC Financial Services both increased their stakes in the business during the same period, showing that institutional investors are taking varied approaches to the high-growth chip sector.

Astera Labs Stock Price Performance

Shares of Astera Labs have shown significant strength, recently trading at $494.40 on Saturday. This price is near the absolute peak of the stock's 52-week range, which spans from a low of $97.89 to a high of $499.48.

This upward movement has pushed the stock well above its long-term technical trend lines. The equity currently trades far higher than its 50-day moving average of $316.57 and its 200-day moving average of $248.58. The company has a current P/E ratio of 148.75862, reflecting high growth expectations, while its forward P/E ratio sits at a more modest 47.161903. The stock exhibits a high beta of 3.69, which indicates it tends to move much more sharply than the broader market.

Strong Financial Fundamentals

In its most recent financial disclosures, Astera Labs reported annual revenue of $1,201,918,976. The company is growing rapidly, posting revenue growth of 104.5%. This expansion has been highly profitable, with the business achieving a net margin of 30.742002% and a return on equity of 25.826%. Astera Labs maintains a highly liquid balance sheet, evidenced by a current ratio of 10.054 and a quick ratio of 9.164, while keeping its debt-to-equity ratio low at 2.574. Investors looking for updates on these growth figures can watch for the next quarterly earnings release, which is scheduled for November 3, 2026.

Insider Buying and Selling at Astera Labs, Inc.

Inside the company, there has been some recent selling activity. Director Bethany Mayer sold 686 shares on June 24, 2026, at an average price of $395.04, yielding a total transaction value of $270,998.67. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan, which allows insiders to set up automatic selling schedules in advance. Following this transaction, she continues to hold 686 shares directly.

Wall Street Analysts Raise Targets

Wall Street firms have been active in revising their price targets and ratings on Astera Labs. On August 17, 2026, Northland Capital Markets upgraded the stock from its previous rating to Outperform, setting a price target of $350.00. Earlier, on August 5, 2026, TD Cowen maintained its Hold rating but lowered its price target from $425.00 to $375.00. On the same day, Morgan Stanley maintained an Overweight rating and lifted its target to $382.00 from $335.00, while RBC Capital maintained an Outperform rating and bumped its target to $500.00 from $425.00.

Other major firms also raised targets on August 5, 2026: Evercore ISI Group kept its Outperform rating and raised its target to $452.00, Needham maintained a Buy rating with a $425.00 target, and Jefferies kept its Buy rating with a target of $450.00. Earlier on July 31, 2026, Susquehanna maintained a Neutral rating with a target of $275.00. Across 22 analyst opinions, the consensus recommendation remains a buy, with a mean price target of $391.77.

About the Company

Astera Labs designs and sells advanced semiconductor connectivity products that help manage data flow in cloud and artificial intelligence infrastructure. Its hardware and software solutions enable large cloud providers and hyperscalers to optimize resources and keep their hardware running efficiently. As AI data centers require increasingly complex networking systems, the demand for high-speed connectivity solutions has become a key driver of the company's financial success.

What's Ahead for Astera Labs, Inc.

Investors will want to keep a close eye on how Astera Labs performs as it approaches its next earnings date on November 3, 2026. Whether the company can continue to beat expectations and justify its premium valuation will be a major factor in whether institutional investors like Mai Capital Management continue to expand their positions in the future.